TITLE

Clinical and Biological Basis of Lung Cancer Prevention

PUB. DATE
February 1999
SOURCE
Thorax;Feb1999, p188
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
66898687

 

Related Articles

  • Lung cancer. 9: Molecular biology of lung cancer: clinical implications. Fong K M; Sekido Y; Gazdar A F; Minna J D; Fong, K M; Sekido, Y; Gazdar, A F; Minna, J D // Thorax;Oct2003, Vol. 58 Issue 10, p892 

    It has been hypothesised that clinically evident lung cancers have accumulated many different genetic or epigenetic abnormalities in oncogenes and/or tumour suppressor genes. This notion has important clinical ramifications. Recent developments in our knowledge of the molecular biology of lung...

  • The possible prevention of cancer. Cairns, John // Environmental Health: A Global Access Science Source;2011 Supplement 1, Vol. 10 Issue Suppl 1, p1 

    The prevention of the infectious diseases was accomplished long before there was any understanding of the molecular biology of bacteria and viruses. As for cancer, the sharp drop in frequency of the once-commonest lethal cancer, stomach cancer, was achieved without any contribution from...

  • Lung Cancer Screening. Mulshine, James L.; Sullivan, Daniel C. // New England Journal of Medicine;6/30/2005, Vol. 352 Issue 26, p2714 

    Offers a look at the efficacy of lung cancer screening in the prevention and treatment of the disease. Incidence of lung cancer and lung cancer-related mortality in the U.S. each year; Potential for the early detection of lung cancer using high-resolution computed tomography (CT); Discussion of...

  • Epidemiology of Cancer and Aging. Balducci, Lodovico // Journal of Oncology Management;Spring2005, Vol. 14 Issue 2, p47 

    The incidence of cancer increases with age. Given the increasing older population, one may expect that by the year 2030 about 70% of all malignancies will occur in individuals aged 65 and older. The following information is obtained from clinical epidemiology: the elderly are more vulnerable...

  • New molecularly targeted therapies for lung cancer. Sun, Sophie; Schiller, Joan H.; Spinola, Monica; Minna, John D. // Journal of Clinical Investigation;Oct2007, Vol. 117 Issue 10, p2740 

    Lung cancer is the leading cause of cancer death worldwide. The disease is particularly difficult to detect, and patients often present at an advanced stage. Current treatments have limited effectiveness, and unfortunately, the prognosis remains poor. Recent insights into the molecular...

  • Prognostic and predictive biomarkers in lung cancer. A review. Thunnissen, Erik; Oord, Kimberly; Bakker, Michael // Virchows Archiv;Mar2014, Vol. 464 Issue 3, p347 

    In lung cancer, clinically relevant prognostic information is provided by staging. Staging forms the basis for the treatment options and this is briefly summarized in the introduction. Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase are biomarkers used for prediction of...

  • Multilevel modeling and value of information in clinical trial decision support. Yuanyuan Cui; Murphy, Brendan; Gentilcore, Anastasia; Sharma, Yugal; Minasian, Lori; Kramer, Barnett S.; Coates, Paul M.; Gohagan, John K.; Klenk, Juergen; Tidor, Bruce // BMC Systems Biology;2014, Vol. 8 Issue 1, p157 

    Background Clinical trials are the main method for evaluating safety and efficacy of medical interventions and have produced many advances in improving human health. The Women's Health Initiative overturned a half-century of harmful practice in hormone therapy, the National Lung Screening Trial...

  • Non-Small Cell Lung Cancer: New Hope for a Chronic Illness. Tyson, Leslie B. // Oncology Nursing Forum;Sep2007, Vol. 34 Issue 5, p963 

    The article proposes everyday interventions that nurses can use to help control tobacco use to prevent lung cancer. It notes that control of tobacco use, new information on the molecular biology of lung cancer and modern developments in treatment can lead to curtailment of lung cancer and...

  • Role of various carotenoids in lung cancer prevention. Knekt, Paul; Jarvinen, Ritva; Teppo, Lyly; Aromaa, Arpo; Seppanen, Ritva // JNCI: Journal of the National Cancer Institute;01/20/99, Vol. 91 Issue 2, p182 

    Presents information on a study which examined the role of various carotenoids in lung cancer prevention. Analysis of the data from the Finnish Mobile Clinic Health Examination; Association of the intake of alpha-carotene with lung cancer; Carotenoids considered which showed associations that...

  • In Brief.  // JNCI: Journal of the National Cancer Institute;12/15/2004, Vol. 96 Issue 24, p1811 

    Reports on developments related to clinical trials for cancer in the U.S. as of December 15, 2004. Basis for the selection of potential candidates for government scientific and technical advisory committees for cancer research; Approval of the tyrosine kinase inhibitor Tarceva for the treatment...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics